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Abstract
Objective: Cholelithiasis represents a very frequent health problem with higher prevalence 
in developed countries. The aim of this chapter is to underline, also by submitting our surgi-
cal experience, some diagnostic deceptions and the timing of treatment.
Methods: The presentation of 42 patients admitted in our institution (September 2012/
September 2014) with the diagnosis of acute pancreatitis allows to identify two differ-
ent clinical forms of acute biliary pancreatitis: the pancreatic pattern and biliary pattern. 
Moreover, the evaluation of another 42 patients observed in our institution (September 
2014/September 2016) with acute cholecystitis should show our treatment program. Also, 
we added the analysis of our previous research, regarding acute cholecystitis, already pub-
lished: difficult cholecystectomy, antegrade dissection in laparoscopic cholecystectomy, 
postoperative morbidity, laparoscopic approach in cirrhotics, finally the robotic experience.
Results: Clinical features, laboratory, and imaging exams should identify, into acute bili-
ary pancreatitis, two clinical forms as biliary pattern and pancreatic pattern for different 
therapeutic approach. The treatment chosen for acute cholecystitis is early laparoscopic cho-
lecystectomy within 24–72 hours. Severe, complicated acute cholecystitis can require urgent 
surgical intervention.
Conclusion: Acute cholecystitis encompasses clinical forms with various degree of severity 
and several clinical courses. The treatment is focused on early cholecystectomy with various 
and different management strategies, suitable to the specific pathological conditions.
Keywords: acute cholecystitis, acute pancreatitis, cholelithiasis, cholecystectomy, 
laparoscopic approach
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1. Introduction
Cholelithiasis represents a very frequent health problem. The prevalence of cholelithiasis is 
higher in the developed regions such as Europe and North America in comparison to the 
developing regions of the world (Africa, Middle East, China, India, Far East). On average, 
gallstone disease affects 10–15% of the adulthood population in the age of majority [1, 2]. The 
cost of gallstone disease has high social, administrative, and economic impact as interference 
with work activities, home care, hospital admission, and so on. Mortality rate for gallstone 
disease reaches 0.6%, thanks to the reduction of more than 50% over the last 60 years [3]. 
Gallstone disease in its evolution involves acute cholecystitis and some risks of complications 
such as gallstone-related pancreatitis and cancer [4, 5]. Moreover, cholecystectomy morbid-
ity encompasses various and diversified pathological conditions especially in severe inflam-
matory circumstances. We underline the problems connected with insufficient preoperative 
evaluation. Complications can be divided in intraoperative and postoperative. Intraoperative 
morbidity includes bile duct injury, gallbladder perforation, bleeding, and bowel perforation. 
Postoperative complications consist of infection and dehiscence of surgical incision, subhe-
patic abscess, residual choledocolithiasis, postcholecistectomy syndrome, umbilical hernia. 
Currently, cholecystectomy morbidity rate reaches 8.7–9.5% with up 15% in so-called difficult 
cholecystectomy. Among these complications is in evidence the bile duct injury which causes 
great impact on patient outcomes and requires usually complex and various procedures of 
repair: endoscopy, surgery, operative biliary radiology [6].
2. Etiology and pathogenesis of gallstones
Various etiological conditions and risk factors can cause gallstone disease. We can underline 
the gender, age, obesity, fast weight loss, alcohol use, diabetes, pregnancy, hypertriglyceride-
mia, and so on. The study of pathogenesis of gallstones can identify all etiological factors. The 
majority of gallstones are non-pigmented stones which are composed of cholesterol (75% of 
cases). The cholesterol is retained in solution by an unsteady balance among levels of phos-
pholipids, bile acids, and cholesterol (Admirand’s triangle) [7]. This balance can be disrupted 
by several factors: cholesterol supersaturation in bile, crystal nucleating factors because choles-
terol supersaturates tends to precipitate and crystallize, impairment of gallbladder functions 
as motility, absorbtion, secretion, finally impaired enterohepatic circulation of bile acids that 
changes the balance of Admirand’s triangle. In summary, cholesterol stones are caused by cho-
lesterol iperproduction, large cholesterol-phospholipid vesicles, crystal precipitation (choles-
terol monohydrate crystal) [8]; moreover, by calcium nucleation, and other nucleating factors 
as mucin glycoproteins, immunoglobulins, and so on. In addition, impairment of gallbladder 
functions plays a significant role: decrease of motility with stasis as in prolonged fasting and 
parenteral nutrition, diabetic disease, long-term somatostatin therapy, alteration of absorptive, 
secretive activity with increase of water reabsorption. Finally, the reduction of intestinal reab-
sorption of bile acids in the entero-hepatic circulation is also in evidence. Crystallizations of 
cholesterol within bile form biliary sludge and biliary sludge can be considered a common 
precursor of the gallstones. Pigmented stones consist of calcium-bilirubinate. These stones 
Updates in Gallbladder Diseases24
are due to  solubilization of unconjugated bilirubin with precipitation. There are two types: 
black and brown. Black stones reach about 15–20% of global biliary stones. They are caused 
and occur in several diseases: hemolytic disorders (increased red blood cell destruction), liver 
diseases, cirrhosis (abnormal metabolism of hemoglobin), distal ileal resection (reabsorption 
of bile salts), and long-term total parenteral nutrition (TPN). Commonly these stones form in 
gallbladder. Brown stones, on the contrary, are found in biliary ducts as primary common bile 
duct (CBD) stones. These stones are associated with infection in bile ducts. Bacteria (Escherichia 
coli, Klebsiella frequently) produce bacterial beta-glucuronidase; consequently deconjugated 
bilirubin, not hydrosoluble, forms calcium bilirubinate. Biliary infections are commonly associ-
ated with biliary ducts stenosis, ampullary stenosis, abnormal sphincter of Oddi, sclerosing 
cholangitis, cirrhosis.
3. Epidemiology and pathophysiology of acute cholecystitis
Symptoms or complications of gallstones can develop in 1–2% of the patients for years [9]. 
Clinical presentation of cholelithiasis can be various: in the majority of cases (60–80%) lithiasis 
stay on long asymptomatic or for the patient’s whole life and its detection could be incidental. 
Symptoms of different degree, mild or severe for advanced complications occur in the 20–40% of 
patients. Acute cholecystitis is the very frequent surgical entity that occurs in 15–20% of patients 
with symptomatic disease. Cholecystitis could be caused by obstruction of the cystic duct by a 
gallstone with the same pathogenesis of biliary colic. The obstacle of bile outflow from gallblad-
der causes its wall distention and wall inflammation. This pathological condition may develop 
in different ways. In the severe cases (10–18%), the prolonged and complete obstruction causes 
extension of parietal flogosis resulting in disturbance of blood perfusion and necrosis. In the 
favorable cases, which are the majority, the stone moves, obstruction resolves, and inflammation 
may regress. In the acute cholecystitis, bacterial superinfection can occur in 50% of cases with 
positive bile culture (Escherichia coli, Klebsiella, Enterobacter, etc.) [10]. We can believe that acute 
cholecystitis starts as inflammatory disease without bacterial infection. Recently more complex 
pathogenesis has been hypothesized in acute cholecystitis. Acute cholecystitis should be pro-
duced with the addition of irritating factors of gallbladder mucosa to the blockage of the cystic 
duct. Lysolecithin has been used in experimental setting as irritant; but lysolecithin comes by 
catalyzation from lecithin, normal constituent of bile, by phospholipase A. Trauma of impacted 
gallstone may cause the release of this enzyme [11]. Moreover, lysolecithin was found in the 
gallbladder with acute inflammation [12]. Gallbladder flogosis should be worsened by further 
inflammatory mediators such as prostaglandins, which play an important role in functional 
activity of gallbladder (motility, fluid absorption, etc.) [13]. In summary, prolonged obstruc-
tion of gallbladder neck leads the increase of intraluminal pressure, with venous congestion, 
impaired blood supply, and lymphatic drainage. Damage of gallbladder wall (edema, intramural 
haemorrhage) and secondary bacterial infection complete the pathological features. Acalculous 
cholecystitis is acute inflammatory disease associated with right upper abdominal quadrant 
pain, leucocitosis, thickened wall without gallstones (ultrasonography (US) findings). Most fre-
quently, it happens in patients with severe disease such as severe burns, trauma, major surgery, 
long-term TPN; frequently cholecys`titis can develop with high morbidity and mortality [14]. 
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In the acute acalculous, cholecystitis probably can play a role of the bile stasis (fasting, narcosis) 
causing distension of wall, impaired blood supply, necrosis. Increased viscosity by dehydration 
and intestinal dynamic occlusion produces sludge formation and bacterial overgrowth in the 
gallbladder. US shows gallbladder wall thickening, sludge, pericholecystic fluid.
4. Clinical presentations of gallstone disease
Gallstones disease can present and develop in the wide clinical range. Asymptomatic disease 
can be detected incidentally. The absence of symptoms is linked to the mobility of stones 
that will not obstruct the cystic duct. The presence of gallstones, although asymptomatic for 
a prolonged time, can develop in symptomatic disease with various clinical entities. Most 
simple and frequent presentation is biliary colic characterized by abdominal pain localized in 
right upper abdominal quadrant, nausea, vomiting, frequently irradiating to the right shoul-
der. Usually the colic lasts a few hours. Asymptomatic patients can develop symptomatic 
disease in 20–30% of cases in the long term (20 years). The clinical developments of gall-
stone disease encompass several presentations: biliary colic, acute cholecystitis (with various 
degree of severity such as gangrene, emphysematous cholecystitis, perforation, cholecysto-
enteric fistula, gallstone ileus), choledocolithiasis, cholangitis, biliary pancreatitis, gallblad-
der carcinoma. The significant clinical problem is the surgical indication of cholecystectomy 
for patients with asymptomatic gallstone. The overall likelihood of clinical appearance for 
asymptomatic patients should be about 30% but we have to insert it and evaluate it in specific 
conditions: demographic, pathophysiological, and clinical. Another relevant information for 
the surgical indication choice is the incidence of postoperative morbidity of cholecystectomy. 
From the literature, overall morbidity (minor and major) of cholecystectomy in the laparo-
scopic era for uncomplicated gallstone disease in patients without comorbidity is very low: 
overall complication rate is 1.5% and the mortality rate is less than 0.1% [15]. In summary, sur-
gical treatment is the first choice in the patients with symptoms, cholecystitis, and gallblad-
der stone-related complications. Moreover, nowadays, the surgical indication for patients 
completely asymptomatic is debatable and not well defined. We can identify several clinical-
pathological conditions without clear and evident clinical appearance in which laparoscopic 
cholecystectomy should be indicated: patients with mild clinical appearance such as intense 
discomfort in the right upper quadrant, nausea vomiting, biliary colic because considerable 
risk for developing complications, young patients because high likelihood to develop in later 
years symptoms or/and complications, patients with pigmented stones caused by hemolytic 
disorders (increased red blood cells destruction) because the risks linked to this pathology in 
case of gallstone-related complications, patients with clearly established gallbladder dysfunc-
tion that frequently develops symptomatic disease (25–30% of cases) [16], patient with large 
stones (>2 cm) for high risk to develop cholecystitis, patients with porcelain gallbladder (cal-
cifications in the wall) because of the risk of gallbladder cancer (5–10%).
4.1. Common clinical presentation of acute cholecystitis
Patients with mild symptomatic gallstone disease such as recurrent biliary colic or mild 
postprandial discomfort can develop in about 20% of cases acute cholecystitis. This path-
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ological evolution commonly is connected with obstruction by stones of gallbladder neck 
or cystic duct. The time duration of the obstructive condition (short or long time) can lead 
to decrease and resolution of inflammatory process or, on the contrary, to wall distension, 
impaired blood supply, ischemia, necrosis of gallbladder (severe cases 15–20%). In about 
50% of cases, commonly in the prolonged impairment of bile outflow from the gallbladder, 
bacterial infection adds to flogistic process. In acute cholecystitis, patients complain of severe 
pain in abdominal right upper quadrant and overall the clinical presentation is overlappable 
to biliary colic but the characteristic pain is on the contrary prolonged greater than 4–6 hours. 
Usually fever, nausea, anorexia, and vomiting join and the pain should be referred to right 
shoulder or back. Frequently the patients refer previous episodes of biliary colic, or fatty 
food ingestion few hours before the onset of colic. Clinical observation shows the suffering 
patient with fever, tachycardia, nausea, emesis, anorexia, and inhibition or diminution of the 
respiratory movement of right upper quadrant and epigastric area of abdominal wall. On 
physical examination can be seen right upper quadrant tenderness of varying degree and 
positive Murphy’s sign with increased discomfort and/or inspiratory arrest while, palpating 
right upper quadrant, the patient is invited to make deep inspiration. A positive sign shows 
sensitivity of 97% and specificity of 93% [17]. In some cases (about 30%), acute cholecystitis 
can develop discrete extension of inflammation outside gallbladder wall causing local perito-
nitis with involvement of omentum and adjacent organs that forms a flogistic mass, palpable 
in upper right quadrant. Leukocytosis is an almost constant laboratory finding characterized 
by the white cell count increase, connected with the severity of the disease.
4.2. Deceptions of clinical diagnosis of acute cholecystitis
Cholelithiasis is the most frequent cause of acute pancreatitis. Clinical diagnostic difficulties 
may arise in the context of acute biliary pancreatitis. The major clinical problem is to dis-
tinguish clinical forms of hyperamylasemia, associated with severe abdominal pain, physi-
cal signs of upper abdominal tenderness and guarding based on acute biliary tract disease 
(acute cholecystitis, cholangitis, etc.) from acute biliary pancreatitis with evident pancreatic 
involvement. In the context of acute biliary pancreatitis may merge acute abdominal dis-
eases different to each other; but they have in common hyperamylasemia and acute/severe 
upper abdominal pain and abdominal wall guarding. The correct diagnosis and distinction 
between moderate or severe acute biliary pancreatitis with hyperamylasemia, evident pancre-
atic involvement, severe upper abdominal pain/abdominal wall guarding, and acute biliary 
tract disease (cholecystitis, cholangitis, etc.) with hyperamylasemia, severe upper abdomi-
nal pain, abdominal wall guarding, minimal, or mild pancreatitis, allows to follow different 
therapeutic program overall in regard to timing of surgery [18]. Our aim is to define clinical 
and laboratory differentiation between these two clinical manifestation regarding the choice 
of therapeutic program. The presentation of consistent and appropriate experience should 
clarify some diagnostic difficulties, within the acute biliary pancreatitis, between two clinical-
pathological forms different but confusable. We have evaluated 42 patients admitted in our 
Institution in the period September 2012/September 2014. The admission diagnosis was acute 
pancreatitis, based on first basic clinical and laboratory evaluation. Demographic features: 
male 26, female 16, mean age 64 years (range: 89–27 years). Signs and symptoms of 42 patients 
at the admission are reported in (Figure 1).
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In the first phase of the study, the patients have been divided by etiology of acute pancreatitis. 
The majority of cases (30 pts. 71%—Group A) shows biliary etiology, based on the detection 
with imaging study (US) of biliary lithiasis. In seven patients (Group B—16.6%), the clinical-
anamnestic criteria show the alcoholic etiology (prolonged alcohol abuse). The other five 
patients (Group C—11.9%) have been classified as acute pancreatitis patients with unknown 
etiology. The patients subdivided following the etiological criteria (Groups A, B, C) have been 
evaluated regarding to severity of disease with Ranson criteria, pancreatic involvement with 
CT severity index (Balthazar), and finally likelihood of biliary etiology with Blamey criteria 
using clinical and laboratory data (age, sex, amylase, alkaline phosphatase, ALT) [19–22]. The 
important section of this study concerns the biliary pancreatitis. Within 30 patients with ini-
tial diagnosis of acute biliary pancreatitis (Group A), we have identified two subgroup: the 
first subgroup A1 that encompasses 18 patients with acute biliary pancreatitis with moderate/
severe pancreatic involvement and the subgroup A2 that includes 12 patients with acute biliary 
disease and minimal pancreatic involvement based on transient hyperamylasemia. The aim of 
this subdivision and comparison is to identify, by laboratory and imaging study, two different 
clinical forms of acute pancreatitis: the pancreatic pattern (A1) and the biliary pattern (A2). 
The patients have been subdivided in three groups following the etiology criteria: biliary 
(Group A), alcoholic (Group B), and undefined pancreatitis (Group C). First, we can evaluate if 
there are differences among the groups of patients regarding clinical severity (Ranson score), 
degree of pancreatic involvement (CT severity index-Balthazar), and finally the likelihood of 
biliary etiology (Blamey score). The evaluation of clinical severity (Ranson score) between the 
group A (biliary) and group B (alcoholic) shows no differences with Student’s t-test: t = 0.1375 
< t0.05 = 1.6896. Because of the low number of cases in our groups, we have also employed the Kolmogorov-Smirnov test for the comparison of clinical severity (Table 1).
Figure 1. Frequency (%) of signs and symptoms in patients with diagnosis of acute pancreatitis.
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The results of the severity disease comparison (CT severity index) show that there are not 
statistically significant differences between group A versus group B and between group B ver-
sus group C. The comparison between group A versus group C shows also no differences 
(empirical p value < theoretical p value) even if in the group C there are mild pancreatitis and 
in group A there are severe pancreatitis. The comparison among the three groups of degree of 
pancreatic and extrapancreatic damage (CT severity index-Balthazar) demonstrates that, even 
in this area, there are not statistically significant differences (Table 2).
Finally the evaluation of the predictive accuracy of biliary etiology based on clinical data 
(Blamey score) among the three groups did not provide effective results for the early defini-
tion of the biliary etiology because of no statistical differences (Table 3).
Group Aa versus Group Bb D = 0.205 < D0.05 = 0.554
Group A versus Group Cc D = 0.634 < D0.05 = 0.640
Group B versus Group C D = 0.429 < D0.05 = 0.800
*Kolmogorov-Smirnov test.
aGroup A: biliary.
bGroup B: alcoholic.
cGroup C: undefined.
Table 1. Comparison of clinical severity between group A, group B, and group C*.
Group Aa versus Group Bb t = 0.4345 < t0.05 = 1.609
Group A versus Group Cc t = 0.2884 < t0.05 = 1.6939
Group B versus Group C t = 0.2006 < t0.05 = 1.8595
*Student’s t-test.
aGroup A: biliary.
bGroup B: alcoholic.
cGroup C: undefined.
Table 2. Comparison of CT severity index between group A, group B, and group C*.
Group Aa versus Group Bb t = 0.0568 < t0.05 = 1.6896
Group A versus Group Cc t = 0.9195 < t0.05 = 1.6924
Group B versus Group C t = 0.8594 < t0.05 = 1.8125
*Student’s t-test.
aGroup A: biliary.
bGroup B: alcoholic.
cGroup C: undefined.
Table 3. Comparison of Blamey score between group A, group B, and group C*.
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To identify the two subgroups A1 (pancreatic pattern) and A2 (biliary pattern) within the 
group A (acute biliary pancreatitis) have been used clinical features, laboratory, instrumental 
tests (imaging), therapeutical procedures employed. We have verified if there are statistically 
significant differences between group A1 and group A2 with respect to leukocytosis, amyla-
semia, bilirubin, aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline 
phosphatase, clinical severity score (Ranson), modified CT severity index (Balthazar). The 
purpose of the study is to identify clinical or instrumental criteria for detection of pancreatic 
pattern versus biliary pattern in acute biliary pancreatitis. In the statistical evaluation, leu-
kocytosis, amylasemia, and alkaline phosphatase did not show differences between the two 
groups. On the contrary, there are differences for bilirubin, AST, and ALT. The results of com-
parison, among subgroups A1 and A2, of clinical severity score (Ranson) and modified CT 
severity index (Balthazar) are different with statistical significance with Student’s t-test but not 
following Kolmogorov-Smirnov test (Table 4).
Finally, we have compared the results of clinical severity score and modified CT severity index 
respectively within the subgroup A1 (Figure 2) and subgroup A2 (Figure 3).
In the subgroup A1 (pancreatic pattern), the results of two scores are overlappable (covari-
ance = 0.000177 > 0). Otherwise in the subgroup A2, the data of the two scores are discordant. 
The results of this section of our study allow several considerations. First, we can identify 
in the group A (acute biliary pancreatitis) two subgroups: A1 (pancreatic pattern) and A2 
(biliary pattern). In the subgroup A2, the pancreatic involvement (valued with modified CT 
severity index) was mild (pancreatic edema); on the contrary, in the subgroup A1, the pan-
creatic damage was moderate/severe or severe (Grade C2, D3); the difference between the 
two groups is statistically significant with Student’s t-test not with Kolmogorof-Smirnov test. 
The clinical severity (Ranson score) was comparable in both groups and of middle level. 
The comparison of bilirubin, AST, ALT shows impairment significant in the subgroup A2; 
not significant the differences for amylasemia, leukocytosis, and alkaline phosphatase. The 
therapeutic program followed the indication of clinical evaluation. The first approach is 
based on medical treatment: fluid-electrolyte replacement, control of pain, nutrition, control 
of papillary flow and, if necessary removal of persistent papillary obstacle. Patients (18) with 
Student’s t-test Kolmogorov-Smirnov test
White blood cells t = 0.2918 < t0.05 = 1.7011 D = 0.22 < D0.05 = 0.500
Amylasemia t = 0.8754 < t0.05 = 1.7011 D = 0.203 < D0.05 = 0.500
Bilirubin t = 2.0192 < t0.05 = 1.7011 D = 0.72 < D0.05 = 0.500
AST t = 2.1664 < t0.05 = 1.7011 D = 0.67 < D0.05 = 0.500
ALT t = 8.7062 < t0.05 = 1.7011 D = 0.78 < D0.05 = 0.500
Phosphatase t = 0.6253 < t0.05 = 1.7011 D = 0.39 < D0.05 = 0.500
Ranson’s score t = 1.8477 < t0.05 = 1.7011 D = 0.363 < D0.05 = 0.500
Balthazar’s index t = 1.8585 < t0.05 = 1.7011 D = 0.416 < D0.05 = 0.500
Table 4. Comparison within acute biliary pancreatitis between subgroup A1 and A2 with Student’s t-test and Kolmogorov-Smirnov test.
Updates in Gallbladder Diseases30
pancreatic  pattern (subgroup A1), after initial medical treatment, followed by improvement 
of general conditions and pancreatic involvement, have been treated 7–10 days after onset 
of disease with cholecystectomy (13 pts.). In five patients with cholestatic index and persis-
tent CBD dilation was planned magnetic resonance cholangiopancreatography (MRCP) and 
endoscopic retrograde cholangiopancreatography (ERCP)/endoscopic sphincterotomy prior 
the cholecystectomy, delayed for few days but in the same hospital stay. All cholecystec-
tomies were performed with laparoscopic approach. On the other hand, patients (12) with 
biliary pattern (subgroup A2) because severe damage of general condition, imminent risk 
of developing severe sepsis, clinical/instrumental evidence of biliary inflammatory disease 
Figure 2. Correspondence between Ranson’s score (X) and Balthazar’s index (Y) in the A1 subgroup in acute biliary 
pancreatitis.
Figure 3. Correspondence between Ranson’s score (X) and Balthazar’s index (Y) in the A2 subgroup in acute biliary 
pancreatitis.
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within acute biliary pancreatitis, underwent emergency surgery (48 hours from onset). The 
intraoperative findings were acute cholecystitis (6), within two cases choledocolithiasis and 
cholangitis, in six cases gangrenous cholecystitis. In these patients was present pancreatic 
edematous impairment. The conversion rate of these procedures was 16.6% (2/12). In both 
subgroups, postoperative morbidity was Grade I and Grade II according to Clavien-Dindo 
criteria. In the subgroup A2, mortality rate was 8.3% (1/12) [23]. We can conclude that it 
seems possible to identify two types of acute biliary pancreatitis for which the therapeutic 
approach should be different. The pancreatic pattern characterized by preeminent pancreatic 
involvement requiring conservative treatment following the severity and evolution of pan-
creatitis; not delayed cholecystectomy, control, and treatment of papillary obstacle if present, 
prolonged control of pancreatic and peripancreatic fluid-necrotic collections, and so on. The 
biliary pattern is characterized by persistent, severe acute biliary tract disease, accompanied 
by mild or moderate acute biliary pancreatitis. This clinical-pathological condition should 
undergo urgent surgical intervention to treat the septic-inflammatory disease (acute chole-
cystitis, cholangitis, etc.).
5. Pathological features of acute cholecystitis
Acute cholecystitis can develop some inflammatory complications that give rise to severe patho-
logical conditions, gangrenous cholecystitis, gallbladder empyema, emphysematous cholecysti-
tis, perforation of gallbladder, cholecystoenteric fistula, and gallstone ileus. These complications 
are life-threatening with risk of severe sepsis and septic shock evolution, peritonitis, and so on; it 
is mandatory urgent surgical procedure. Gangrenous cholecystitis is a very dangerous compli-
cation because of the difficulty of preoperative detection. Gangrene is the development of wall 
phlogosis, impaired blood supply, wall ischemia, gangrene; the final development of this compli-
cation can be the perforation. Gangrene is not frequent complication and perforation can occur 
in 5–10% of these patients. Gangrene as complication of acute cholecystitis occurs frequently in 
patients with compromised clinical conditions: diabetes, trauma, severe burns, prolonged TPN 
and stay in intensive care unit, cardiac surgery. Frequently perforation is localized in a circum-
scribed peritonitis, characterized by pericholecystic abscess limited with omentum and surround-
ing organs. Free perforation causes generalized peritonitis, accompanied by severe impairment 
of clinical course such as abdominal wall guarding, fever, increase of leukocytosis, start of severe 
sepsis and septic shock. Gallbladder empyema results as pus collection in the gallbladder because 
of bacterial overgrow. Obviously, the septic site can initiate severe sepsis and septic shock. The 
clinical picture is severe with abdominal pain in upper right quadrant, leukocytosis, fever, and 
tachycardia. Initial medical treatment with broad-spectrum antibiotics must be followed by 
urgent cholecystectomy. In the emphysematous cholecystitis is added the superinfection of gas-
forming organisms (Clostridium Welchii, Escherichia coli, Klebsiella, etc.) [24]. This complication is 
uncommon and usually develops in males, old and diabetics patients. The most frequent evolu-
tion of gallbladder wall emphysema (75% of cases) is gangrene and perforation. Clinical course 
develops severe sepsis and septic shock. Imagine exams (CT scan) show gas in the gallbladder 
wall. Emergency surgery should be the correct treatment.
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Cholecystoenteric fistula can be due to dual pathogenesis: long-standing pressure necro-
sis by large stones and flogistic adhesion of gallbladder wall with adjacent hallow organs, 
followed by pathological communication. Most frequent communications are with duo-
denum (70–85%) and right flexure of the colon (15–20%) [25]. Cholecystoduodenal fis-
tula allows the passage into the small intestine of gallstones, usually of large size that 
cause decubital effect. The stone progress in small intestine and in the narrowest part, 
frequently ileum, stops and determines mechanical obstruction, that is gallstone ileus 
(about 15% of patients with cholecystoenteric fistula). Clinical course of gallstone ileus 
develops as common intestinal obstruction. In the past decades, this clinical condition 
appeared in the characteristic way: acute cholecystitis treated with medical therapy, 
in 7–10 days improvement of signs and symptoms (decompression of the gallbladder 
because the fistula forms), in the following several days appearance of clinical features 
of intestinal obstruction (gallstone ileus). In the therapeutic program, the first step is the 
resolution of intestinal obstruction by enterotomy and stone removal. The treatment of 
 cholecystoduodenal  fistula should be performed in the same time or delayed for impaired 
general conditions of patients.
In the uncomplicated cholecystitis, usually there are no increase of serum total and direct 
bilirubin and alkaline phosphatase (cholestasis indexes). If the signs of cholestasis occur, 
may be due to choledocolithiasis, cholangitis, or the Mirizzi syndrome. There are two 
types of Mirizzi syndrome: in type I, a large stone blocked in the cystic duct and in the 
Hartmann’s pouch of gallbladder compresses the common bile duct but without fistula 
between gallbladder and common hepatic duct. In the type II, due to necrosis of wall 
of common hepatic duct, there is a fistula with various degrees of defect of hepatic duct 
wall and presence of stone in hepatic duct. The first type can be treated with “partial” 
cholecystectomy and repair of bile duct with T-tube. The type II requires more complex 
procedure with complex dissection and hepaticojejunostomy. On the other hand, there are 
patients, in course of acute cholecystitis, with mild increase of amylase, AST, ALT, biliru-
bin caused by papillary passage of sludge, pus, and cholesterol crystals [26]. Moreover 
in several cases because transient papillary obstruction during transpapillary passage of 
small stones, can occur elevation of serum transaminase levels (AST, ALT), so called “gall-
stone hepatitis” [27].
6. Imaging studies in acute cholecystitis
6.1. Plain radiography
Plain radiography is not very useful to confirm the diagnosis of acute cholecystitis. In few 
cases, it may detect biliary disease such as biliary stones (only 10–15% of stones contain cal-
cium enough to be radiopaque), gallbladder wall calcified, pneumobilia; but unfortunately, 
these findings are not diagnostic for acute cholecystitis. The role of plain radiography remains 
crucial in any acute abdomen to rule out some pathological condition such as perforated hol-
low organs (pneumoperitoneum), and intestinal obstruction (air fluid levels).
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6.2. Ultrasonography
Transabdominal US should be employed as completion of clinical examination in patients with 
abdominal pain. It is very important to define accurately the reliable data that the US can pro-
vide in different diseases that can cause an acute abdomen. The US can detect gallstones (acous-
tic shadowing behind to the stones) with sensitivity of 84% and specificity of 99% [28–30]. We 
have to remember some features that US can highlight such as mobile gallstones in the gallblad-
der, polyps, small stones attached to the wall, very small stones without acoustic shadow, and 
the fluid absence around the gallstones that make difficult their detection. Finally, there are 
also some false negative exams with US that range from 5 to 15% in acute cholecystitis [31, 32]. 
More crucial for the diagnosis of acute cholecystitis are the gallbladder wall edema or pneuma-
tosis (“double wall sign”) and wall thickening; both features of inflammation condition. US can 
detect bile duct dilation and also the site of obstacle if present. The US can add some information 
about pericholecystic fluid collection or inflammatory mass in upper right abdominal quadrant 
but the complete definition of these findings should be obtained by CT scan.
6.3. Abdominal computed tomography
CT scan has limited role in the diagnostic confirmation of uncomplicated acute cholecystitis 
because the same information and sensitivity of US (presence of gallstones, gallbladder wall 
thickening, dilation of CBD). On the contrary, CT scan is crucial in the diagnostic definition of 
complications such as pericholecystic fluid, gallbladder empyema, emphysematous gangrene, 
perforation, limited peritonitis with inflammatory mass, intrahepatic and extrahepatic bile 
duct dilation, choledocolithiasis, concomitant pancreatitis, hepatic lesions.
6.4. Magnetic resonance imaging
Magnetic resonance imaging (MRI) as CT scan is of little help in the diagnosis of simple acute 
cholecystitis. On the other hand, MRI is very sensitive in detecting the morphology of biliary 
tract, gallstones, and bile duct stones. Moreover, it is a noninvasive technique in the study of 
intra- and extrahepatic biliary ducts [33, 34]. Cholescintigraphy, noninvasive test, allows ana-
tomic and functional evaluation of liver, gallbladder, bile duct. This nuclear medicine exam 
uses intravenous injection of hepatic 2, 6-dimetyl-imidodiacetic acid (HIDA) that is rapidly 
excreted in the bile. Cholescintigraphy allows the functional evaluation of hepatic ability to 
extract the radionuclide, the flow into the biliary ducts and gallbladder and finally the passage 
into the duodenum within 30–60 min. In the acute cholecystitis, cystic duct obstruction by 
stones prevents to visualize the gallbladder; also, stones in the common bile duct or papillary 
obstacle prevent the passage of radionuclide into the duodenum. The sensitivity and specific-
ity of HIDA test in detecting acute cholecystitis reach 90–95% [35]. In our experience, we do not 
have used this exam that nowadays is less frequently used.
7. Treatment
The first approach in patients with acute cholecystitis includes fluid resuscitation, analgesia, 
suspension of oral intake, nasogastric tube, broad-spectrum antibiotics. This therapeutic scheme, 
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while widely shared, may subject to small variations in timing of each therapeutic measures 
and in the choice of the antibiotic. Should be discussed the use of nasogastric tube if it can be 
employed widely at the onset of the disease or selectively in case of nausea, vomiting, abdominal 
distention. Control of abdominal pain is an essential therapeutic target. For this purpose, nonste-
roidal anti-inflammatory drugs are widely used for analgesia. These drugs inhibit the activity of 
cyclooxygenase 1 and 2 (COX-1 and COX-2) with critical reduction of prostaglandins formation. 
Prostaglandin E2 plays protective role on epithelial cells of gallbladder by secreting mucin; its 
reduction decreases this mucin production and consequently the distention of gallbladder wall. 
The therapy with a single broad-spectrum antibiotic can be correct for mild or moderate acute 
cholecystitis. In the severe cases should be used more selective antibiotics such as imipenem/
cilastatine, third-generation cephalosporine and metronidazole. Bacteria present in acute cho-
lecystitis are frequently Escherichia coli, Enterococcus, Klebsiella, and so on. In the treatment of 
acute cholecystitis, cholecystectomy plays the central role as standard management. This state-
ment seems seemingly plain and without controversies. There are in the literature several points 
of wide discussion in which we will report also our experience. The timing of the intervention is 
very important topic: the choice between early and delayed cholecystectomy with various opera-
tive outcomes. The first item to make is to define “early intervention.” Within acute cholecysti-
tis, there are several clinical pathological conditions that are the evolution of the inflammatory/
septic process, from mild to severe, life-threatening forms. The reasonable options, always in 
urgent approach, can vary from emergency to intervention within 24–48–72 hours (early proce-
dures). Another consideration adds uncertainty in the choice of timing of intervention because 
the dissection difficulties of inflamed operative site, with the possible increase of intraoperative 
morbidity that can be very severe in both approaches, laparoscopic and open [36].
In our experience about cholecystectomy morbidity, in the group which includes also the acute 
cholecystitis, we have compared the outcomes in two following periods: first period 2006–2008 
and second period 2009–2011. Total morbidity in the second following period was markedly 
reduced from 18.5 to 9.96% (p = 0.009). With regard to morbidity by incomplete preoperative 
evaluation and surgical error, we have defined some criteria to increase the control and pre-
vention: acceptable general anesthesia, clear visibility of surgical site, optimal exposition of the 
hepatic hilum and its structure, control of possible anatomical variations, finally convertion to 
open cholecystectomy if necessary [37]. Employing, since 2002, of antegrade dissection in lapa-
roscopic cholecystectomy as standard technique allows reduction in intervention time (mean 
operative time 40 min) and decrease of the conversion rate (from 3.4 to 0.8%) in the comparison 
with common retrograde approach [38]. Minor postoperative morbidities as wound infections 
can be prevented following correct criteria of medications. In our experience, topical antibiotic 
application may reduce surgical wound infection in umbilical site after laparoscopic cholecys-
tectomy [39]. Concerning the subhepatic collections, in our opinion, the common use of sub-
hepatic drainage after cholecystectomy for acute cholecystitis enables the correct drainage of 
serous and/or serohematic secretions usually present in the first days in inflamed surgical site.
There are in the literature several reviews regarding the timing of early or delayed cholecystec-
tomy and the comparison of its operative morbidity. Tokyo guidelines suggest a therapeutic 
program for acute cholecystitis based on precocious severity assessment as guide for treatment 
choices. Mild acute cholecystitis should undergo early laparoscopic cholecystectomy, within 
72 hours from onset with possible improvement of other medical problems. For moderate 
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forms also should be performed early cholecystectomy with laparoscopic or open approach 
(conversion to open following difficult dissection). Severe acute cholecystitis can show, in 
addition, damage of general conditions (organ dysfunction) which needs to treat. For these 
clinical-pathological conditions, urgent surgery is necessary: the type of surgical procedures 
is connected with pathological findings such as gangrenous or perforated cholecystitis, local 
or generalized peritonitis, involvement of adjacent organs. The urgent procedures vary from 
cholecystecyomy to cholecystostomy, percutaneous gallbladder drainage, and so on. The revi-
sion of Tokyo guidelines [40] confirms the first choice of laparoscopic early cholecystectomy 
but without the exact definition of time of precocious intervention. We can underline that in 
the Tokyo guidelines is reported also the elective cholecystectomy, in all degree of severity, 
after improvement of the acute inflammatory process [41–43]. Nevertheless, another confir-
mation of the validity of early cholecystectomy, within 24 hours, regarding minor morbidity 
and lower cost, has been presented by Gutt CN [44]. More selective criteria have been used in 
order to bind the study of patients with acute cholecystitis excluding very severe forms (need 
of intensive care admission, urgent cholecystostomy, etc.) by Canadian Researchers. They 
employed a population-based analysis (20,000 patients—period 2004–2011) for comparison of 
operative outcomes of early and delayed cholecystectomy [45].
This study showed, in the comparison of delayed cholecystectomy, that early cholecystectomy 
in the treatment of acute cholecystitis was associated with a lower risk of major bile duct injury, 
of operative mortality, of postoperative (30 days) mortality (respectively 1.36 and 0.46%) and 
finally a shorter hospital stay. It is also demonstrated almost same conversion rate between 
early and delayed laparoscopic cholecystectomy. Obviously early cholecystectomy put in a 
safe place for risk of recurrent gallstone disease. Similar results have been reported from other 
studies: early laparoscopic cholecystectomy (performed within 48 hours) is associated to bet-
ter postoperative outcomes with lower morbidity and hospital stay [46, 47]. A very interesting 
French study evaluated the choice for optimal timing for early cholecystectomy [48]. Patients 
with acute cholecystitis from the French National Health Care database have been studied: 
42,452 patient—507 hospitals—period 2010–2013. The exam of the literature shows the thera-
peutic indication of early laparoscopic cholecystectomy as standard procedure for acute chole-
cystitis. Nevertheless, with exception for urgent surgery indications (sometimes with various 
procedures) in case of very severe cholecystitis as perforated, gangrenous forms with local or 
generalized peritonitis, the time of “early surgery” is not well defined. Polo et al. in this study 
show that the optimal time for laparoscopic cholecystectomy in acute cholecystitis is between 
the first and third day after hospital admission. In this time interval is recorded lower risk 
of mortality and lower morbidity: common bile duct injury, reoperation rate, postoperative 
sepsis, conversion rate, and finally minor length of hospital stay and cost. The definition of 
best time for surgical procedure always has an element of uncertainty because it is very dif-
ficult to report the onset of the symptoms and is instead reported the hospital admission. To 
assess the significance of this inaccuracy is very difficult. Moreover, this study report also not 
negligible morbidity and mortality (range from 0.8 to 1.4%) for the patients treated within 
the first 24 hours. This particular result, in our opinion, proves the need, also in the program 
of early cholecystectomy, of a brief time interval for supportive therapy, and resuscitation to 
improve the general condition in patients with severe cholecystitis and septic complications. 
Updates in Gallbladder Diseases36
It is evident in the recent literature that the first, preferred choice for acute cholecystitis is the 
laparoscopic approach with conversion rate ranging from 10 to 15%. The first choice of the 
open approach should be limited to peritonitis, perforated chilecystitis but always as personal 
choice, that cannot be standardized. In the setting of the therapy of acute cholecystitis, we can 
propose the presentation of a series of consistent clinical cases, observed and treated in our 
Institution in the period September 2014–September 2016, to show our treatment program. In 
the chosen period, we have treated 42 patients with acute cholecystitis. Demographic data are 
the following: male 45.2% (19/42), female 54.7% (23/42), mean age 59.6% (range: 20–87 years). 
Furthermore, we have recorded the pathological features of the patients (Table 5).
Therapeutic program in severe cholecystitis with complications, characterized by severe 
morbidity and mortality, demands ready surgical intervention. In our patients with severe 
acute cholecystitis (38%), prompt surgery was performed few hours after hospital admis-
sion; two patients needed preoperative intensive care and they were treated within 24 hours. 
The patients with acute cholecystitis were treated with laparoscopic early cholecystectomy 
performed within 72 hours (range: few hours–72 hours) based on the needs of preoperative 
treatments related to comorbidities. All these interventions start with laparoscopic approach 
and the conversion rate was 21% (9/42). Postoperative outcomes were characterized by minor 
morbidity, no mortality and the postoperative hospital stay was in mean 4.2 days (range: 2–14).
Laparoscopic cholecystectomy for acute cholecystitis, because of the inflammation and severe 
pathological involvement in the operative site, can be in most cases a “difficult cholecystec-
tomy.” Our experience and other from the literature have shown that laparoscopic difficult 
cholecystectomies for acute cholecystitis are safe and effective and are associated with lower 
incidence of minor and major postoperative complications, moreover with several advan-
tages as less respiratory infections, shorter postoperative course, and shorter hospital stay. 
Laparoscopic approach decreases some complications of laparotomy as infections, dehiscence, 
and laparocele [49–51].
There is an impending risk of lesions of common bile duct during cholecystectomy for acute 
cholecystitis. The adoption of an operating procedure that puts at minor risk biliary duct 
lesions should be proposed. Gallbladder antegrade dissection is an operative procedure 
employed also in the past for open cholecystectomy. This well-known type of dissection has 
been proposed in the laparoscopic approach. Several data from the literature demonstrate the 
Acute cholecystitis 26
Severe cholecystitis 16
Hydrope (2/16)
Emphysematous (3/16)
Gangrene/perforation (7/16)
Patients 42
Table 5. Pathological features in acute cholecystitis (September 2014–September 2016).
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frequent use of this operative procedure in difficult cholecystectomy because of acute flogosis 
and the decrease in conversion rate to open with antegrade dissection [52, 53].
In our study, we have compared postoperative results of two groups of patients submitted 
to antegrade dissection and retrograde dissection in laparoscopic approach [54]. This study 
shows that antegrade dissection in laparoscopy for acute cholecystitis with phlogosis of 
Calot’s triangle is safer procedure in comparison to retrograde approach, seems to reduce the 
operative time, and should significantly decrease the risk of intraoperative complications such 
as common bile duct injury and hemorrhages. In our opinion, confirmed by more recent expe-
rience, antegrade dissection may be proposed as a standard procedure of cholecystectomy and 
not only for interventions in the acute cholecystitis [38].
Moreover, there are some specific problems related to urgent cholecystectomy in cirrhotic 
patients. Cholelithiasis in cirrhotics occurs twice as often in the general population with a 
reported incidence of 9–13% versus 5% in non-cirrhotic patients [55]. Major incidence of cho-
lelithiasis is due to several factors with various pathogenesis: hypersplenism, increased level 
of estrogen, increased intravascular hemolysis, reduction in gallbladder emptying, and motil-
ity. In our experience, published some years ago [56], this epidemiologic characteristic was 
confirmed. In this study, we have evaluated 65 cirrhotic patients with symptomatic gallstone 
disease treated with laparoscopic cholecystectomy in the decade 2002–2012. This group of 
patients has been compared with 81 non-cirrhotic patients with symptomatic gallstone dis-
ease, no significant morbidity and no significant differences in demographic data, and under-
went laparoscopic cholecystectomy in the period October 2011–May 2012. Within the group 
of non-cirrhotic patients, the incidence of acute cholecystitis was 13.5% (11/81) and there are 
not further complications; on the contrary, in the cirrhotic group, the incidence of acute cho-
lecystitis reached 27.6% (18/65) with several complications such as 1 cholangitis, 2 gallbladder 
hydrops, 2 gallbladder empyema, 3 gangrenous cholecystitis. The cohort of cirrhotics evalu-
ated by Child-Pough classification shows 43 patients in A score (66.2%), 19 in B score (29.2%), 
and three patients in C score, medically treated preoperatively and reclassified in B8 score. 
Cirrhotic patients have undergone cholecystectomy: six with open approach as first choice, 
59 with laparoscopic procedure with conversion rate 20.3%. The comparison of the results 
between the two cohorts of patients has been evaluated (Table 6).
In this experience, laparoscopic cholecystectomy morbidity in cirrhotic patients is slightly 
increased compared to non-cirrhotics. Moreover, postoperative morbidity in cirrhotic patients 
is minor on the whole with laparoscopic approach than open procedure. Cholecystectomy 
in cirrhotic patients is associated with non-negligible rate of morbidity and mortality. The 
more frequent complications are blood loss, postoperative liver failure, and sepsis [57, 58]. 
Postoperative liver failure is due to the anesthetic agent’s action, which decrease hepatic arte-
rial blood flow (the ability of cirrhotic patients to compensate for this ischemia is impaired) [59]. 
Diminished Kupffer cell function leads to reduced clearance of the enteric organisms, endo-
toxinemia, and risk of infection in cirrhotic patients. The increased risk of bleeding is related 
to reduced prothrombin time, thrombocytopenia, and portal ipertension. Finally, patients 
can have a gallbladder with a significant intrahepatic component due to atrophy of the right 
hepatic lobe and a hypertrophic left lobe with more difficulties for intervention [55, 60–62].
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The last evolution in the surgical treatment of acute cholecystitis is the robotic approach. On 
the whole, the main advantages of robotic surgery can be realized in some phases of complex 
laparoscopic procedures requiring high dexterity and best visualization. In this perspective, 
robotic approach for cholelithiasis and later for acute cholecystitis should be the start of valu-
able learning curve for robotic advanced skills in general surgery. Our experience in the field 
of gallbladder lithiasis confirms the safe feasibility of robotic approach that requires the use 
of standardized procedures. The obvious purpose of this approach, however, in the chole-
cystectomy, is the improvement of the technical skills in advanced and more complex robotic 
assisted surgical procedures [63]. The comparison of the results of laparoscopic versus robotic 
cholecystectomy proves the complete equivalence between both the procedures regarding of 
safety and feasibility in all types of gallbladder’s pathology. In particular, acute cholecystitis 
can be treated with robotic-assisted approach showing postoperative overlapping outcomes 
with symptomatic gallstones disease [64]. On the contrary, the data from a study based on 
the literature search with randomized controlled trials and population-based analyses shows 
that the advantages of current use of robotic surgery in cholecystectomy are not provable [65].
8. Conclusions
Acute cholecystitis encompasses clinical forms with various degree of severity and several 
cases (8–10%) present pathological findings that can make the operative site a surgical chal-
lenge, very difficult to treat. Indeed the laparoscopic approach, worldwide more common 
VLC (47) Open (6) Converted (12)
Operative time (minutes) 88.9 141 149 85
Hospitalization (days) 4.8 9.1 8.1 3.2
Conversion rate 20.34% - - 3 (3.7%)
Mortality - - - -
Blood transfusion in peri-operative time 2 (4.2%) 1 (16.6%) 2 (16.6%) -
Blood products transfusion in peri-
operative time
7 (14.9%) 1 (16.6%) 4 (33.3%) -
Hemoperitoneum 1 (2.12%) - - -
Reintervention 1 (2.12%) - - -
Pleural effusion - - 2 (16.6%) -
Pulmonary condensation - - 1 (8.33%) -
Trombocytopenia - - 1 (8.33%) -
Atrial fibrillation - - 1 (8.33%) -
Incisional hernia on umbilical port site 4 (8.51%) - - 2 (2.46%)
Table 6. Peri- and postoperative morbidity outcomes in cirrhotics (65) and in control group (81).
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choice in the treatment of acute cholecystitis, presents significant conversion rate to open pro-
cedure (10–15%). Furthermore, besides more common clinical, laboratory, and instrumental 
features of acute cholecystitis, there are some diagnostic pitfalls, such as the biliary pattern that 
should be distinguished from the pancreatic pattern in the field of acute biliary pancreatitis. 
The treatment is focused on early laparoscopic cholecystectomy well defined usually within 
24–72 hours. Nevertheless, severe, complicated acute cholecystitis can require urgent surgical 
intervention. Finally should be evaluated some particular components of a complex clinical 
problem such as laparoscopic antegrade dissection in acute cholecystitis to allow minor risk 
of biliary duct lesions, the control of the specific problems related to urgent cholecystectomy 
in cirrhotic patients, and finally the possible future increased use of robotic approach in the 
treatment of acute cholecystitis.
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